The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer-Reference-Cited by-同舟云学术

The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer

Published:2002-07 Issue:5 Volume:12 Page:355-366
ISSN:0960-314X
Container-title:Pharmacogenetics
language:en
Short-container-title:Pharmacogenetics

Author:

Spurdle Amanda B.,Goodwin Bryan,Hodgson Ecushla,Hopper John L.,Chen Xiaoqing,Purdie David M.,McCredie Margaret R. E.,Giles Graham G.,Chenevix-Trench Georgia,Liddle Christopher

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Pharmacology, Toxicology and Pharmaceutics,Genetics

Reference46 articles.

1. CYP3A gene expression in human gut epithelium

2. Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae

3. Human liver microsomal steroid metabolism: Identification of the major microsomal steroid hormone 6β-hydroxylase cytochrome P-450 enzyme

4. Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP3A5 influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantation;Frontiers in Pharmacology;2024-01-08

2. Targeting Cytochrome P450 Enzymes in Ovarian Cancers: New Approaches to Tumor-Selective Intervention;Biomedicines;2023-10-26

3. Activation/Inactivation of Anticancer Drugs by CYP3A4: Influencing Factors for Personalized Cancer Therapy;Drug Metabolism and Disposition;2023-02-02

4. Genetic association in CYP3A4 and CYP3A5 genes elevate the risk of prostate cancer;Annals of Human Biology;2023-01-02

5. CYP3A4∗22 Genotyping in Clinical Practice: Ready for Implementation?;Frontiers in Genetics;2021-07-08